InnovAge Q4 2026 Earnings Call Summary

1Key Financial Results and Metrics

Census Growth: Served approximately 8,230 participants, a 6.3% increase year-over-year.

Revenue: Total revenue for fiscal 2026 was $989.7 million, a 15.9% increase driven by higher member months and capitation rates.

Adjusted EBITDA: Increased to $94.6 million for fiscal 2026, up from $34.5 million in fiscal 2025, with an adjusted EBITDA margin of 9.6%.

Net Loss: Reported a net loss of $0.7 million for fiscal 2026, significantly improved from a net loss of $35.3 million in fiscal 2025.

Fourth Quarter Performance: Revenue was $262.0 million, and net income was $9.8 million, compared to a net loss of $29.9 million in the previous quarter.

2Strategic Updates and Business Highlights

InnovAge 3.0: The company is transitioning to a new phase focused on scaling capabilities and expanding its value-based care platform.

Operational Improvements: Enhanced leadership, technology, and data management have led to better cost management and operational discipline.

Technology Investments: Significant investments in AI and technology to improve clinical decision-making, participant experience, and operational efficiency.

Leadership Changes: Jen Browne joined as President and COO, focusing on improving consistency across centers and enhancing participant experience.

3Forward Guidance and Outlook

Fiscal 2027 Targets:

Expected ending census between 8,625 and 8,850 participants (5% to 7.5% growth).

Projected total revenue of $1.05 billion to $1.085 billion.

Adjusted EBITDA forecasted between $105 million and $115 million.

Rate Environment: Anticipated to be more tempered than fiscal 2026, with Medicare rate increases of 1.5% to 2% and low single-digit increases for Medicaid.

4Bad News, Challenges, or Points of Concern

Legal Accruals: One-time legal accruals impacted net income, highlighting ongoing litigation and settlement expenses.

Rate Uncertainty: The finalization of rates in key markets (California and Colorado) remains pending, creating potential revenue uncertainty.

Cost Pressures: Increased costs in salaries, wages, and benefits, alongside rising fleet and administrative costs, could pressure margins.

Competitive Pressures: The company faces competition during open enrollment periods, particularly affecting census growth in Q3.

5Notable Q&A Insights

PMPM Trends: Management discussed factors influencing PMPM assumptions, including county-level rates and risk adjustments related to the V28 model transition.

Strategic Priorities: Focus on maximizing capacity in existing centers before pursuing new centers through M&A or de novo opportunities.

Policy Discussions: Engaging with policymakers to explore expanding PACE capabilities to new populations, particularly Medicare-only beneficiaries with functional impairments.

Operational Efficiency: Emphasis on disciplined margin management and efficiency improvements through data analytics and AI to enhance care delivery and reduce costs. This summary encapsulates the key takeaways from InnovAge's Q4 2026 earnings call, highlighting financial performance, strategic initiatives, future guidance, and areas of concern.